Investigational vaccine with recombinant human albumin (rHA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational vaccine with recombinant human albumin (rHA), covering 2017-03-15 to 2017-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) [Phase 2]